|
1
|
Caserta S, Kern F, Cohen J, Drage S,
Newbury SF and Llewelyn MJ: Circulating plasma microRNAs can
differentiate human sepsis and systemic inflammatory response
syndrome (SIRS). Sci Rep. 6(28006)2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tracey KJ: The inflammatory reflex.
Nature. 420:853–859. 2002.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fleischmann C, Scherag A, Adhikari NK,
Hartog CS, Tsaganos T, Schlattmann P, Angus DC and Reinhart K:
International Forum of Acute Care Trialists. Assessment of global
incidence and mortality of Hospital-treated sepsis. Am J Respir
Crit Care Mede. 193:259–272. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Angus DC, Linde-Zwirble WT, Lidicker J,
Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis
in the United States: Analysis of incidence, outcome, and
associated costs of care. Crit Care Med. 29:1303–1310.
2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cho W, Koo JY, Park Y, Oh K, Lee S, Song
JS, Bae MA, Lim D, Lee DS and Park SB: Treatment of sepsis
pathogenesis with high mobility group box protein 1-regulating
anti-inflammatory agents. J Med Chem. 60:170–179. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Adib-Conquy M and Cavaillon JM: Stress
molecules in sepsis and systemic inflammatory response syndrome.
FEBS Lett. 581:3723–3733. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lyle NH, Pena OM, Boyd JH and Hancock RE:
Barriers to the effective treatment of sepsis: Antimicrobial
agents, sepsis definitions, and host-directed therapies. Ann N Y
Acad Sci. 1323:101–114. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Silman NJ: Rapid diagnosis of sepsis using
biomarker signatures. Crit Care. 17(1020)2013.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Wang H, Bloom O, Zhang M, Vishnubhakat JM,
Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et
al: HMG-1 as a late mediator of endotoxin lethality in mice.
Science. 285:248–251. 1999.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gonelevue S, Bandyopadhyay A, Bhagat S,
Alam MI and Khan GA: Sterile inflammatory role of high mobility
group Box 1 protein: Biological functions and involvement in
disease. J Vasc Res. 55:244–254. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao
L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and
disease. Mol Aspects Med. 40:1–116. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Magna M and Pisetsky DS: The role of HMGB1
in the pathogenesis of inflammatory and autoimmune diseases. Mol
Med. 20:138–146. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ulloa L and Tracey KJ: The ʻCytokine
Profileʼ: A code for sepsis. Trends Mol Med. 11:56–63.
2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang H, Yang H and Tracey KJ:
Extracellular role of HMGB1 in inflammation and sepsis. J Intern
Med. 255:320–331. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gibot S, Massin F, Cravoisy A, Barraud D,
Nace L, Levy B and Bollaert PE: High-mobility group box 1 protein
plasma concentrations during septic shock. Intensive Care Med.
33:1347–1353. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Andersson U and Tracey KJ: HMGB1 is a
therapeutic target for sterile inflammation and infection. Annu Rev
Immunol. 29:139–162. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kingsley SMK and Bhat BV: Role of
microRNAs in sepsis. Inflamm Res. 66:553–569. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bulun SE and Nezhat C: Aromatase,
microRNA, and inflammation: A complex relationship. Fertil Steril.
106:552–553. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Essandoh K and Fan GC: Role of
extracellular and intracellular microRNAs in sepsis. Biochim
Biophys Acta. 1842:2155–2162. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yao Y, Sun F and Lei M: miR-25 inhibits
sepsis-induced cardiomyocyte apoptosis by targetting PTEN. Biosci
Rep. 38(BSR20171511)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ma Y, Liu Y, Hou H, Yao Y and Meng H:
MiR-150 predicts survival in patients with sepsis and inhibits
LPS-induced inflammatory factors and apoptosis by targeting NF-κB1
in human umbilical vein endothelial cells. Biochem Biophys Res
Commun. 500:828–837. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Benz F, Roy S, Trautwein C, Roderburg C
and Luedde T: Circulating MicroRNAs as biomarkers for sepsis. Int J
Mol Sci. 17(78)2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a~27a~24-2 cluster and its implication in human diseases. Mol
Cancer. 9(232)2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gusar VA, Timofeeva AV, Zhanin IS, Shram
SI and Pinelis VG: Estimation of Time-dependent microRNA expression
patterns in brain tissue, leukocytes, and blood plasma of rats
under photochemically induced focal cerebral ischemia. Mol Biol
(Mosk). 51:683–695. 2017.PubMed/NCBI View Article : Google Scholar : (In Russian).
|
|
25
|
Lozano-Bartolomé J, Llauradó G,
Portero-Otin M, Altuna-Coy A, Rojo-Martinez G, Vendrell J, Jorba R,
Rodríguez-Gallego E and Chacón MR: Altered expression of
miR-181a-5p and miR-23a-3p is associated with obesity and
TNFα-induced insulin resistance. J Clin Endocrinol Metab.
103:1447–1458. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Parker MI and Palladino MA: MicroRNAs
downregulated following immune activation of rat testis. Am J
Reprod Immunol: 77, 2017 doi: 10.1111/aji.12673.
|
|
27
|
Ge QM, Huang CM, Zhu XY, Bian F and Pan
SM: Differentially expressed miRNAs in sepsis-induced acute kidney
injury target oxidative stress and mitochondrial dysfunction
pathways. PLoS One. 12(e0173292)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen X, Liu Y, Gao Y, Shou S and Chai Y:
The roles of macrophage polarization in the host immune response to
sepsis. Int Immunopharmacoly. 96(107791)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhou W, Wang J, Li Z, Li J and Sang M:
MicroRNA-2055b inhibits HMGB1 expression in LPS-induced sepsis. Int
J Mol Med. 38:312–318. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (Sepsis-3). JAMA.
315:801–810. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen W, Ma X, Zhang P, Li Q, Liang X and
Liu J: miR-212-3p inhibits LPS-induced inflammatory response
through targeting HMGB1 in murine macrophages. Exp Cell Res.
350:318–326. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C,
Dalamagas T and Hatzigeorgiou AG: DIANA-microT web server v5.0:
Service integration into miRNA functional analysis workflows.
Nucleic Acids Res. 41:W169–W173. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Stevens NE, Chapman MJ, Fraser CK, Kuchel
TR, Hayball JD and Diener KR: Therapeutic targeting of HMGB1 during
experimental sepsis modulates the inflammatory cytokine profile to
one associated with improved clinical outcomes. Sci Rep.
7(5850)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yang H, Ochani M, Li J, Qiang X, Tanovic
M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, et al:
Reversing established sepsis with antagonists of endogenous
high-mobility group box 1. Proc Natl Acad Sci USA. 101:296–301.
2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Charoensup J, Sermswan RW, Paeyao A,
Promakhejohn S, Punasee S, Chularari C, Krabkraikaew S,
Lertanekawattana S and Wongratanacheewin S: High HMGB1 level is
associated with poor outcome of septicemic melioidosis. Int J
Infect Dis. 28:111–116. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Guo ZS, Liu Z, Bartlett DL, Tang D and
Lotze MT: Life after death: Targeting high mobility group box 1 in
emergent cancer therapies. Am J Cancer Res. 3:1–20. 2013.PubMed/NCBI
|
|
38
|
Andersson U, Yang H and Harris H:
Extracellular HMGB1 as a therapeutic target in inflammatory
diseases. Expert Opin Ther Targets. 22:263–277. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Deng M, Tang Y, Li W, Wang X, Zhang R,
Zhang X, Zhao X, Liu J, Tang C, Liu Z, et al: The endotoxin
delivery protein HMGB1 mediates Caspase-11-dependent lethality in
sepsis. Immunity. 49:740–753.e7. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim HM and Kim YM: HMGB1: LPS delivery
vehicle for caspase-11-mediated pyroptosis. Immunity. 49:582–584.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wu D, Pan P, Su X, Zhang L, Qin Q, Tan H,
Huang L and Li Y: Interferon regulatory factor-1 mediates alveolar
macrophage pyroptosis during LPS-induced acute lung injury in mice.
Shock. 46:329–338. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yuan Z, Luo G, Li X, Chen J, Wu J and Peng
Y: PPARγ inhibits HMGB1 expression through upregulation of
miR-142-3p in vitro and in vivo. Cell Signal. 28:158–164.
2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Park EJ, Kim YM, Kim HJ and Chang KC:
Degradation of histone deacetylase 4 via the TLR4/JAK/STAT1
signaling pathway promotes the acetylation of high mobility group
box 1 (HMGB1) in lipopolysaccharide-activated macrophages. FEBS
Open Bio. 8:1119–1126. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lee W, Ku SK and Bae JS: Zingerone reduces
HMGB1-mediated septic responses and improves survival in septic
mice. Toxicol Appl Pharmacol. 329:202–211. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Quan J, Pan X, Li Y, Hu Y, Tao L, Li Z,
Zhao L, Wang J, Li H, Lai Y, et al: miR-23a-3p acts as an oncogene
and potential prognostic biomarker by targeting PNRC2 in RCC.
Biomed Pharmacother. 110:656–666. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zhao H, Tao Z, Wang R, Liu P, Yan F, Li J,
Zhang C, Ji X and Luo Y: MicroRNA-23a-3p attenuates oxidative
stress injury in a mouse model of focal cerebral
ischemia-reperfusion. Brain Res. 1592:65–72. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Minnich DJ and Moldawer LL: Anti-cytokine
and anti-inflammatory therapies for the treatment of severe sepsis:
Progress and pitfalls. Proc Nutr Soc. 63:437–441. 2004.PubMed/NCBI View Article : Google Scholar
|
